Other studies have failed to show prognostic values of LRP immunoreactivity in acute leukaemia (Damiani et al, 1998; Leith et al, 1999) and ovarian carcinoma (Arts et al, 1999). The gene discussed is MVP; the disease is ovarian carcinoma.